V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)DeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
HomeGlossaryHold-Time Study
Manufacturing · The complete guide

hold time study: meaning, evidence and controls

In short

Understand how a hold time study connects material condition, elapsed time and study evidence to a defensible manufacturing limit.

4,197 words · ~20 min read
Hold time study context: gowned operator sampling a held intermediate container tagged HOLD, tablet timer on cart
Decisions depend on the product, jurisdiction and approved procedure.
On this page
  1. 01What a hold time study establishes—and what it does not
  2. 02Separate material holds from neighbouring terms and regulatory scopes
  3. 03Define the material, container, conditions and clock before testing
  4. 04Choose worst cases by deterioration mechanism, not convenience
  5. 05Select chemical, microbial and physical evidence for suitability
  6. 06Sample the material without creating a different hold condition
  7. 07Worked cases: split containers, accumulated waits and sampling artefacts
  8. 08Approve the limit and assess departures without automatic extension
  9. 09Carry the study into operations and recover missing events
  10. 10Keep the evidence chain from protocol to material disposition
  11. 11Implement the study through a proportionate readiness checklist
  12. 12Review the evidence when materials, conditions or processing change
On this page · 12 sections
  1. 1What a hold time study establishes—and what it does not
  2. 2Separate material holds from neighbouring terms and regulatory scopes
  3. 3Define the material, container, conditions and clock before testing
  4. 4Choose worst cases by deterioration mechanism, not convenience
  5. 5Select chemical, microbial and physical evidence for suitability
  6. 6Sample the material without creating a different hold condition
  7. 7Worked cases: split containers, accumulated waits and sampling artefacts
  8. 8Approve the limit and assess departures without automatic extension
  9. 9Carry the study into operations and recover missing events
  10. 10Keep the evidence chain from protocol to material disposition
  11. 11Implement the study through a proportionate readiness checklist
  12. 12Review the evidence when materials, conditions or processing change
AI · Explain it for MY operation

How does Hold-Time Study apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01What a hold time study establishes—and what it does not

A hold time study is a planned evaluation of how long an in-process material or intermediate remains suitable for its next manufacturing step under defined conditions.

The study concerns a specified material at a specified process stage, held in a defined container and environment. Suitability is assessed against justified quality attributes relevant to its intended use. Unlike an isolated in-process check, the study examines whether suitability is maintained over the hold period.

  • The proposed operating limit is the duration the manufacturing process is intended to permit.
  • The duration actually studied is the period covered by the study’s observations under its defined conditions.
  • The limit ultimately approved is the operating boundary justified by the results and their applicability to routine manufacture; it need not equal the longest duration tested.

A study therefore supports a bounded decision, not an unlimited period of suitability. Its conclusion applies to the material, stage and conditions assessed, rather than every later use of that material.

Chemical degradation, microbial growth or physical change may limit a hold; their relevance depends on the material and process. For distinctions from administrative status and equipment cleanliness, see the comparison of material, status and equipment holds below.

02Separate material holds from neighbouring terms and regulatory scopes

In manufacturing practice, these terms support different decisions. Identify the controlled object before selecting evidence or treating an existing study as applicable.

TermControlled objectClock or triggerDecision supported
In-process material holdMaterial or intermediateDefined processing endpointsSuitability for subsequent processing
Batch hold statusBatch authorizationAdministrative restriction and clearanceWhether activity may proceed
Dirty equipment holdUsed equipment and residuesProcessing completion to cleaningAcceptable delay before cleaning
Clean equipment holdCleaned equipmentDefined cleaning endpoint to reuseContinued suitability for use
Temperature exposure assessmentMaterial under thermal exposureRecorded exposure historyImpact of actual conditions
Expiry or retest datingStored material or productAssigned dating referenceUse or retesting decision

Administrative status is not a material-age clock: clearing a restriction does not reset material aging. Equipment cleanliness is a different study object. Temperature history is an exposure input, not a substitute for material-specific evidence such as a blend hold study.

FrameworkJurisdiction or reachProduct scopeRole in this article
21 CFR 211.111United StatesFinished drugsBinding-law reference; check current scope
ICH Q7International guidanceAPIs and intermediatesProcessing, equipment and dating recommendations
WHO TRS 992 Annex 4International guidancePrimarily non-sterile solid dosage formsMaterial hold-time study design
Practical study recommendationsOperational, not jurisdictionalMaterial and process under assessmentStudy-design principles, not legal obligations

For US finished drug manufacturing, check the current text of 21 CFR 211.111 for scope; keep this binding-law reference separate from international guidance.

For API manufacturing, international ICH Q7 section 6.41 recommends processing-step and/or total-process time limits, where appropriate. For API and intermediate manufacturing, international ICH Q7 section 5.21 recommends a maximum interval between processing completion and equipment cleaning, when appropriate. That equipment recommendation is distinct from bulk-material evidence.

For pharmaceutical manufacturing, international WHO TRS 992 Annex 4 focuses primarily on hold-time study design for non-sterile solid dosage forms. For pharmaceutical manufacturing, the international WHO Annex 4 overview excludes cleaning-validation hold times, API manufacturing and biologicals.

For APIs, international ICH Q7 section 11.61 recommends basing expiry or retest dating on evaluation of stability-study data.

For food, supplements, devices and chemicals, use the operation-specific implementation checklist as practical study-design support. Identify sector and market obligations separately rather than importing pharmaceutical provisions by analogy.

03Define the material, container, conditions and clock before testing

A practical study protocol identifies the material at a specific manufacturing stage, including its processing history, and defines observable start and stop events before results are collected. Processing completion, discharge, container closure, transfer completion and commencement of the next operation are different events; none is a universal boundary. Select boundaries that represent the exposure being studied, and identify how each event will be recorded in the process event log. If closure starts the clock, explain how exposure before closure is addressed rather than silently excluding it.

Define elapsed hold as the continuous interval between the approved boundary events. Define accumulated hold as the sum of explicitly identified intervals under an approved counting rule. For accumulated holds, classify intervening processing, transfers and repeated waits: which intervals count, which are evaluated separately, and what scientific rationale supports any exclusion or reset. An administrative pause does not itself establish a scientific clock exclusion. Naming a new operation step does not demonstrate that earlier exposure no longer matters.

Describe the container material, closure, geometry, fill, headspace and product-contact surfaces, together with the handling pattern. Specify relevant environmental conditions, agitation, light exposure and protective atmosphere. Record operating ranges from the actual process specification rather than proposing generic setpoints. Include changes during the hold, such as movement between areas or opening and reclosing containers, so the study represents the intended production exposure rather than an undisturbed laboratory substitute.

Finally, connect the proposed duration to the observations needed to judge suitability for the named downstream operation. Define what condition the material needs to retain for that operation to work as intended; an acceptable observation at the end of storage alone may not answer that question. This scope provides the basis for selecting credible worst-case configurations, discussed next, before choosing sampling points. Treat the proposed duration as a study question, not an established operating limit.

04Choose worst cases by deterioration mechanism, not convenience

In practical study design, worst cases are mechanism-dependent. Consider credible combinations of material variability, process history, container configuration, fill, environmental exposure, handling and downstream sensitivity. Use the batch execution history to identify plausible sequences. Greatest duration, largest vessel and smallest fill need not identify the same challenge: duration affects exposure, vessel geometry affects settling, and fill changes headspace and exposed surface relative to material quantity.

Select only mechanisms relevant to the material. The following matrix illustrates challenge-to-measurement links, not prescribed tests or conditions. Do not combine mutually incompatible operating conditions into an artificial challenge.

MechanismPlausible challengeAttribute and observation point
Moisture uptakeHumid exposure during openingWater content after opening sequence
OxidationAir contact during transfersOxidative degradants after transfers
SettlingQuiescent suspensionConcentration by depth before remixing
Microbial proliferationGrowth-supporting material and conditionsMicrobial counts across the hold
Solvent lossEvaporation through closureSolvent content at hold end
SegregationPowder movement during handlingComposition across discharge fractions

For each selected challenge, document why its measurable attribute and observation point can reveal deterioration relevant to subsequent processing; an endpoint composite may conceal spatial differences.

Bracketing is a reasoned coverage argument, not automatic permission to group products or containers. Explain which configurations are represented and why. Base study-unit selection and run strategy on variability, prior knowledge, sampling design and the decision supported—not borrowed process-validation or stability-program batch counts. See the study execution examples for operational consequences when a configuration lacks support.

05Select chemical, microbial and physical evidence for suitability

As study-design practice, select attributes by the material’s deterioration risks and its next manufacturing step. The candidates below are conditional on product and stage, not a mandatory test panel.

MechanismCandidate attributeMethod considerationConsequence for the next step
Chemical degradation or impurity formationAssay; relevant degradants or impuritiesResolve relevant changes despite matrix interferenceReduced potency or impurity carryover
Moisture or solvent changeWater content; solvent contentLimit preparation-related evaporation or uptakeAltered reaction, drying or compaction behaviour
Microbial growth or contaminationMicrobial level; objectionable organisms where relevantDemonstrate recovery despite inhibitory matrix effectsIncreased downstream microbial burden
Physical segregation or settlingSpatial composition; sedimentation; redispersibilityAvoid preparation that masks heterogeneityNonuniform feed or dosing
Loss of processabilityViscosity; flow; filterabilityUse a test representative of downstream handlingImpaired transfer, filtration or filling

For chemical change, a stability-indicating method needs to distinguish the change of concern from ordinary analytical variation. Consider sensitivity to the relevant change, sample preparation that could create or remove it, and matrix effects that could obscure it. Method suitability concerns the held intermediate itself; performance on a finished product does not necessarily transfer.

Suitability for the next step is broader than passing a convenient finished-product test. Subsequent blending may conceal segregation, concentration may amplify an impurity increase, and filtration may leave dissolved degradants unchanged. Do not assume later processing repairs deterioration.

Set acceptance logic and trend interpretation before evaluating results. Baseline evidence establishes starting condition; endpoint evidence tests suitability at the proposed boundary. Intermediate observations help distinguish progressive change from variability. Consider both absolute acceptability and change from baseline, using predefined treatment of uncertain or inconsistent findings. Connect interpretation to sampling that preserves representativeness.

06Sample the material without creating a different hold condition

For API and intermediate manufacturing addressed by international ICH Q7 guidance, section 8.34 recommends scientifically sound sampling plans and procedures. The practical design question is whether sampling preserves the production exposure being studied.

Repeated access to a study vessel follows the same material over time, but opening it can admit air or moisture; withdrawing material changes fill volume and headspace. Remixing can conceal settling, while introducing a sampling tool can introduce contamination. Separate representative units assigned to observation points avoid repeated disturbance, but their filling, closures and storage may differ from the production vessel. Neither design is inherently representative: justify the choice against actual production handling, including whether routine access or mixing occurs.

For non-uniform materials, choose sampling locations that can reveal gradients, layers or settled fractions rather than relying only on a convenient access port. Distinguish independent study units from repeated withdrawals or replicate tests of the same sample; they answer different questions about variability. Establish baseline observations, then place later observations around scientifically relevant changes, such as expected separation or deterioration. Select frequency from the material and mechanism, not a universal schedule.

Keep material hold duration, sample collection time, transport history and laboratory preparation distinct. Define sample preservation, transport conditions and analytical handling, including any mixing before testing. Record these through sample login and handoff and link them to traceable study and operational records. This separation helps distinguish deterioration in the production container from changes after collection; delayed preparation or unsuitable preservation can otherwise create a misleading laboratory artefact.

07Worked cases: split containers, accumulated waits and sampling artefacts

These hypothetical cases illustrate timing logic, not process specifications. All timestamps use a common time basis expressed in hours; subtracting them gives durations in hours. Calculating a duration and deciding whether study evidence covers the actual hold are separate tasks.

Split containers with a common start

Assume a homogeneous intermediate is split into containers A and B after processing completes. The approved clock starts at that common event, t_complete, and stops when each container enters the next processing step: t_A_use or t_B_use. Container identities remain connected through bin-level lot genealogy.

A later closure timestamp, t_A_close or t_B_close, does not replace t_complete. If t_B_use > t_A_use, then H_B − H_A = t_B_use − t_A_use > zero hours. Container B therefore has the longer elapsed hold, regardless of closure order.

Separate waits around an intervening operation

Assume an in-process intermediate waits before and after an intervening operation. Its overall boundary runs from t_initial_start to t_final_use. Each separately defined waiting interval has duration d_defined_hold_interval = t_interval_end − t_interval_start. Assume these waiting intervals do not overlap.

CaseAssumed boundary ruleDuration expressionUnitDecision enabled
Container ACompletion to A's next-step startH_A = t_A_use − t_completehoursCompare A's elapsed hold with its applicable limit
Container BCompletion to B's next-step startH_B = t_B_use − t_completehoursCompare B's elapsed hold with its applicable limit
Overall elapsed holdInitial start to final useH_elapsed = t_final_use − t_initial_starthoursEvaluate the entire elapsed period
Accumulated waitsOnly intervals included by the approved counting ruleH_accumulated = Σ d_defined_hold_intervalhoursEvaluate the defined cumulative waiting exposure

Elapsed duration includes the intervening operation; accumulated duration answers how much defined waiting occurred. Only the approved counting rule determines membership in the accumulated measure. Do not add overlapping intervals to calculate a single material's wall-clock duration. Comparing H with an approved limit addresses timing only: container, condition and attribute coverage remain relevant.

Sampling that changes the exposure

Assume moisture-sensitive granules await further processing in closed production containers, while a small study container is repeatedly opened for sampling. Define t_granule_complete as hold start and t_sample as collection: H_sample = t_sample − t_granule_complete, in hours.

Any observed moisture change needs interpretation: does it represent closed-container storage, sampling-induced exposure, or both? Compare separate representative sampling units kept closed until collection with an intentionally reopened-container challenge. The former investigates the routine closed hold; the latter investigates opening exposure. Container scale, fill and closure comparability matter in that comparison; neither design is automatically acceptable. Refer the interpretation to the approved-limit and exception process, using exception-based review to connect the exposure difference with the disposition decision rather than treating the calculated duration as proof of suitability.

08Approve the limit and assess departures without automatic extension

As a study-design practice, evaluate a proposed operating limit against the materials and conditions represented, the study observations, analytical suitability and variability between batches, containers and samples. Consider trends and uncertainty, not just whether individual results passed. A limit supported under one container configuration or exposure condition is not necessarily supported under another. There is no practice-based universal maximum; a favourable observation does not independently authorize extrapolation beyond the evidence.

For a departure, a practical quality assessment follows this sequence:

  1. Identify the affected material, batch and containers, and the operating limit against which the departure is assessed.
  2. Preserve the actual duration and condition history, including uncertainty or missing events; do not replace the original history with a revised timer value.
  3. Evaluate potential quality impact using relevant study observations, process knowledge and available analytical evidence. Explain where that evidence does not represent the actual exposure.
  4. Document the scientific rationale, decision, any restrictions on subsequent use and the authorized approver.

Keep a batch-specific disposition separate from a permanent revision of the operating limit. The latter calls for justification covering future routine use, not merely acceptance of the affected batch. Passing a selected retest does not by itself establish an automatic extension or reset. Authorized humans approve dispositions and batch release decisions; a timer or software status is not that decision.

Translate the approved decision into operating instructions and exception recovery, retaining the scope and revision of the limit rather than only its duration.

09Carry the study into operations and recover missing events

A practical operating instruction identifies the material stage, start and stop events, applicable limit revision, container scope, expected conditions, timing owner and escalation route. Record condition excursions separately from excessive duration, even when both affect the same material: resolving a timing discrepancy does not resolve an exposure concern.

Define information exchanges rather than assuming connectors exist. Link batch and container identity, equipment events, environmental records, laboratory samples and results, and quality decisions. Identify the authoritative record for each event, using a process event log where appropriate. Specify whether timestamps represent occurrence, entry or receipt; define time zones, clock synchronization and duration units. Use clock drift monitoring to help identify disagreements between recording systems.

For a missing start event, preserve the gap and assess the plausible exposure interval rather than substituting the discovery time. Retain duplicate stop observations while identifying which represents the defined stop. For offline entries, distinguish occurrence time from later entry time. Investigate clock disagreement without overwriting original timestamps. Map container relabelling to the previous identity; after partial transfer, track transferred material and the remainder separately. Preserve original observations, correction history and the basis for any reconstruction. Escalate unresolved uncertainty so an unverified reconstruction cannot silently become a new clock origin.

Evaluate software by asking: can reviewers reconstruct elapsed time, identify all affected material and retrieve corrections with their reasons? Can uncertainty remain visible through human disposition? These questions test evidence handling, not automatic enforcement or release. Connect recurring exceptions to lifecycle review triggers.

10Keep the evidence chain from protocol to material disposition

As a practical record-design pattern, retain linked protocol and report revisions, material-stage and study-unit identities, container configuration, condition records, actual collection timestamps, methods, results, acceptance rationale and approval decisions. A final summary alone is difficult to interpret: without event-to-sample relationships, reviewers cannot reconstruct which exposure each result represents. Link sample handling through the chain of custody. Set retention through applicable requirements and site policy, not a universal study period.

The following relationship map separates experimental observations from routine production holds while connecting both to shared material-stage and boundary definitions:

  • Protocol revision → study units: identifies the design governing each unit.
  • Study unit → samples → results: connects observations to collection events and exposure.
  • Approved report evidence → operational limit revision: records the basis for the limit put into use.
  • Operational hold → decision record: connects actual production exposure to the disposition rationale and approver.

Useful fields include material_stage_id, boundary_rule_id, conditions_spec_id, method_revision, result_unit, event_source and corrected_event_ref. Preserve raw values and their units alongside interpreted outcomes; link corrections to original events rather than replacing them invisibly. Keep study-unit identifiers distinct from production-hold identifiers. Refer ambiguous event interpretation back to the material and clock definition, so a later reviewer can distinguish a changed timestamp from a changed interpretation of the boundary.

A Connected Hold-Time Evidence Model

Study Protocol

Defines approved scope and evaluation logic.

  • protocol_id
  • protocol_revision
  • material_stage_id
  • boundary_rule_id
  • conditions_spec_id

Study Unit

Identifies the material and container challenged.

  • study_unit_id
  • protocol_id
  • lot_id
  • container_id
  • challenge_rationale

Sample result

Connects collection, method and measured attribute.

  • sample_id
  • study_unit_id
  • sampled_at
  • method_revision
  • attribute_id
  • result_value
  • result_unit

Operational Hold

Records actual exposure against an approved revision.

  • hold_id
  • lot_id
  • container_id
  • started_at
  • stopped_at
  • limit_revision

Decision Record

Links supporting evidence and accountable disposition.

  • decision_id
  • hold_id
  • evidence_ref
  • deviation_id
  • disposition
  • approver_id
Link study observations to operational exposure without treating them as interchangeable records.

11Implement the study through a proportionate readiness checklist

Use readiness gates rather than an arbitrary completion deadline. This practical sequence coordinates manufacturing, laboratory and quality work; it is not a universal regulatory workflow.

  1. Map the process stage and the material awaiting its next operation.
  2. Identify applicable sector and market obligations, separating binding requirements from guidance.
  3. Document the hold boundaries, clock definitions, container configuration and conditions.
  4. Select attributes that address material suitability and subsequent processing.
  5. Justify challenge conditions and study units against the deterioration mechanisms.
  6. Approve sampling instructions, acceptance criteria and evaluation logic before execution.
  7. Prepare execution records linking material, container, sample and event identities; use the operational transfer controls as the system-readiness check.
  8. Assign operating responsibilities, laboratory responsibilities and authority for interpreting results and deciding material disposition.

Test the handover using a representative material history. Can an operator identify the correct start event, applicable limit revision, remaining decision needs and escalation owner? Can the laboratory trace a result to the intended study unit and collection event? Resolve ambiguous instructions or missing record links before routine use.

From study boundary to operational review
  1. 1
    Define boundariesIdentify material stage, clock events, containers and conditions.
  2. 2
    Select challengesConnect credible deterioration mechanisms to representative study configurations.
  3. 3
    Plan observationsDefine attributes, sampling, methods and evaluation logic.
  4. 4
    Execute studyCapture actual events, conditions, results and departures.
  5. 5
    Approve limitDocument supported scope, rationale and authorized approval.
  6. 6
    Control operationsApply the approved revision and record actual exposure.
  7. 7
    Review changesAssess new conditions, trends and recurring operational exceptions.
Each transition connects material evidence, an explicit decision and accountable ownership.

12Review the evidence when materials, conditions or processing change

As industry practice, hold-time evidence is reassessed through change control when changes could affect its applicability. Triggers include formulation or supplier changes relevant to stability, altered processing history, new containers or closures, changed fill or scale, revised handling conditions, altered analytical methods and a different downstream operation. Evaluate each against the deterioration mechanisms and conditions represented by the study.

  • Document continued coverage when existing evidence adequately represents the changed configuration.
  • Use a focused bridging study when a bounded uncertainty needs targeted evidence.
  • Use a broader restudy when changed mechanisms or conditions undermine the original study’s applicability.

Choose according to the changed mechanism, uncertainty and available evidence—not automatic portability or identical testing for every change. Recurring operational departures and adverse trends identified through exception-based review also inform reassessment; this practice does not prescribe a universal review interval.

Practical lifecycle: boundary definition → study execution → approval → operational recording → reassessment.

  • Are current clock boundaries still represented?
  • Do material configurations and handling conditions remain covered?
  • Does downstream use remain within the original worst-case justification?

Frequently asked questions

Q.Can development data support routine production before a dedicated commercial hold time study is complete?+

Development data can provide a scientific basis for an interim production decision when the material, process stage, container, conditions and analytical methods adequately represent production. A practical assessment compares those factors explicitly, identifies unresolved scale effects and limits use to the supported conditions. A [batch comparison](/glossary/batch-comparison-overlay) helps organize that assessment. Quality approval, a defined study completion plan and an approach to unexpected results make the interim arrangement controlled; scheduling pressure alone does not establish suitability.

Q.When can a representative study cover several batch sizes or [container types](/glossary/partial-container-handling)?+

Representative coverage is defensible when the grouping follows the mechanisms that could change material quality, rather than nominal capacity alone. Compare contact materials, closure, headspace, fill level, surface exposure, mixing and thermal behavior. Different attributes may have different worst cases, so a single configuration may not bracket everything. Record the covered configurations and exclusions alongside [container status tracking](/glossary/container-status-tracking). Where equivalence remains uncertain, targeted bridging work is more informative than assuming that the largest batch represents every arrangement.

Q.How should a passing result with a [deteriorating trend](/glossary/out-of-trend-handling) affect the attribute evaluation?+

A passing endpoint does not, by itself, demonstrate a comfortable operating margin. Evaluate the direction and consistency of change, analytical variability, batch differences and whether deterioration could compromise subsequent processing. For chemical changes, a suitable [stability-indicating method](/glossary/stability-indicating-method) can help distinguish loss of the desired component from formation of degradants. A practical response may be a shorter proposed hold, additional observations near the endpoint or closer routine surveillance. Avoid projecting beyond the observed period without a justified model.

Q.Does waiting for [laboratory results](/glossary/microbial-test-gate) pause the material's hold clock?+

Waiting for results does not change the material's physical exposure. Under an elapsed-time definition, the interval continues until the specified stop event actually occurs. An accumulated-exposure model can treat time differently only where its definition and supporting evidence justify that treatment; a laboratory queue is not such evidence. Distinguish the material clock from its [batch hold state](/glossary/batch-hold-state): administrative permission to proceed and evidence about material aging answer different questions. Plan laboratory turnaround within the available processing window.

Q.Can refrigerated transfer or an intervening processing step restart a hold?+

Neither movement nor cooling inherently erases previous exposure. A practical assessment carries the existing history forward and asks whether the study covers the transition, including cooling behavior and transfer conditions. An intervening operation can establish a new material stage with its own supported clock, but merely relabeling the stage is insufficient. Use the [process event log](/glossary/process-event-log) to distinguish a genuine transformation from relocation or waiting. Consider whether earlier deterioration persists or affects the newly formed material.

Q.What happens when a sample is missed or tested after its scheduled collection time?+

First distinguish late collection from delayed analysis. Late collection changes the material age represented; delayed analysis raises a separate question about sample preservation and stability. Record actual collection and testing events through the [sample login handoff](/glossary/sample-login-handoff), then assess the affected study conclusion. A later passing sample does not necessarily recover a missed observation, especially for non-monotonic changes. The practical disposition may be qualified use of remaining data, additional sampling or repeat work, with the gap explicitly addressed.

Q.How should a contract manufacturer hand over material that is already partway through its hold?+

A useful [chain of custody](/glossary/chain-of-custody) handover includes material and container identities, the clock-start event and timestamp, elapsed exposure, applicable conditions, excursions, sampling history and the governing limit. Agree who tracks aging during transport and receipt, including any uncertainty between clocks. Remaining time is calculated from the original history, not from receipt. For material split across containers, preserve container-specific differences in the [batch execution history](/glossary/batch-execution-history) rather than reporting an average age that could conceal the oldest portion.

Q.What evidence distinguishes a batch-specific disposition from a permanent increase to the approved limit?+

A batch-specific assessment addresses an identified exposure history and the quality risks for that material. It may use targeted testing, condition records and downstream impact assessment without establishing a generally longer hold. A permanent increase needs evidence representative of the proposed routine scope, including relevant variability, containers, conditions and attributes. Manage that proposal through [change control](/glossary/change-control), with revised instructions and an implementation assessment. Repeated acceptance of exceptional batches is not a substitute for demonstrating the broader operating window.

Primary sources

  • ICH Q7
  • WHO TRS 992 Annex 4 hold-time guidance
Software that covers Hold-Time Study
V5 Ultimate for API Manufacturing
Active Pharmaceutical Ingredient manufacturing under ICH Q7 (Good Manufacturing Practice for APIs) and EU GMP Part II —…
V5 Ultimate (Validation Management)
V5 Ultimate helps life-science sites manage Computer System Validation (CSV) and Computer Software Assurance (CSA) work: linked…
V5 Ultimate (GMP)
V5 Ultimate is a full-lifecycle GMP platform for US and international manufacturers — cGMP under 21 CFR 210/211, EU GMP Parts…
Talk to us about Hold-Time Study

Want to see how Hold-Time Study could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Where this term comes up
PharmaceuticalVet PharmaBlood & TissueFood ProcessingOTC Topicals
Inside V5
  • → eBMR / eDHR — the batch record fills in as the work is done.
Example reports
V5Ultimate

Sample report

Electronic Batch Manufacturing Record (eBMR)

Plan & make

Electronic Batch Manufacturing Record (eBMR)View on screen or print
V5Ultimate

Sample report

Electronic Device History Record (eDHR)

Plan & make

Electronic Device History Record (eDHR)View on screen or print
→ All example reports
Regulatory anchors
  • EU GMP Annex 15
  • ICH Q7
Related terms
  • → Cleaning Validation
  • → PPQ
  • → Deviation
  • → CPV
  • → Bulk-to-Pack Traceability

Next Step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse All Features

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC